Two Sigma Securities’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.39M | Buy |
2,636
+1,645
| +166% | +$923K | 0.12% | 190 |
|
|
2026
Q1 | $557K | Buy |
+991
| New | +$635K | 0.06% | 428 |
|
|
2025
Q4 | – | Sell |
-649
| Closed | -$415K | – | 1728 |
|
|
2025
Q3 | $415K | Buy |
649
+91
| +16% | +$55.2K | 0.06% | 436 |
|
|
2025
Q2 | $299K | Sell |
558
-881
| -61% | -$421K | 0.04% | 663 |
|
|
2025
Q1 | $604K | Buy |
+1,439
| New | +$625K | 0.09% | 286 |
|
|
2024
Q4 | – | Sell |
-441
| Closed | -$193K | – | 2369 |
|
|
2024
Q3 | $223K | Sell |
441
-585
| -57% | -$284K | ﹤0.01% | 2046 |
|
|
2024
Q2 | $500K | Buy |
1,026
+423
| +70% | +$212K | 0.01% | 1546 |
|
|
2024
Q1 | $326K | Buy |
+603
| New | +$330K | ﹤0.01% | 1899 |
|
|
2023
Q4 | – | Sell |
-1,376
| Closed | -$646K | – | 3273 |
|
|
2023
Q3 | $602K | Buy |
+1,376
| New | +$686K | 0.01% | 1397 |
|
|
2023
Q2 | – | Sell |
-1,008
| Closed | -$483K | – | 3045 |
|
|
2023
Q1 | $504K | Sell |
1,008
-1,074
| -52% | -$514K | 0.01% | 1253 |
|
|
2022
Q4 | $849K | Sell |
2,082
-437
| -17% | -$170K | 0.03% | 768 |
|
|
2022
Q3 | $821K | Buy |
2,519
+1,091
| +76% | +$401K | 0.02% | 758 |
|
|
2022
Q2 | $501K | Buy |
1,428
+452
| +46% | +$184K | 0.02% | 915 |
|
|
2022
Q1 | $534K | Sell |
976
-1,254
| -56% | -$660K | 0.02% | 969 |
|
|
2021
Q4 | $1.47M | Buy |
2,230
+1,907
| +590% | +$1.2M | 0.06% | 175 |
|
|
2021
Q3 | $201K | Sell |
323
-361
| -53% | -$243K | 0.01% | 1238 |
|
|
2021
Q2 | $432K | Sell |
684
-1,249
| -65% | -$690K | 0.01% | 741 |
|
|
2021
Q1 | $946K | Buy |
+1,933
| New | +$968K | 0.05% | 168 |
|
|
2019
Q4 | – | Sell |
-846
| Closed | -$230K | – | 2482 |
|
|
2019
Q3 | $230K | Buy |
+846
| New | +$235K | ﹤0.01% | 1755 |
|
|
2019
Q1 | – | Sell |
-3,648
| Closed | -$679K | – | 2109 |
|
|
2018
Q4 | $679K | Buy |
+3,648
| New | +$748K | 0.01% | 831 |
|
|
2018
Q2 | – | Sell |
-2,739
| Closed | -$524K | – | 2796 |
|
|
2018
Q1 | $524K | Buy |
+2,739
| New | +$506K | ﹤0.01% | 1635 |
|
|
2017
Q4 | – | Sell |
-10,774
| Closed | -$1.68M | – | 1853 |
|
|
2017
Q3 | $1.68M | Buy |
+10,774
| New | +$1.7M | 0.15% | 123 |
|
|
2017
Q2 | – | Sell |
-4,492
| Closed | -$695K | – | 999 |
|
|
2017
Q1 | $695K | Buy |
+4,492
| New | +$619K | 0.14% | 141 |
|
Other funds holding IDXX
Two Sigma Securities's IDXX Position: Q2 2026 in Review
Two Sigma Securities increased its Idexx Laboratories (IDXX) stake by 166% in Q2 2026, buying an estimated $923K and bringing the position to 2,636 shares worth $1.39M. The position accounts for 0.12% of the portfolio, ranked #190.
Two Sigma Securities first reported a position in IDXX in Q1 2017 and has held it in 23 quarters since. The position peaked at $1.68M in Q3 2017. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Two Sigma Securities held 2,636 shares of Idexx Laboratories worth $1.39M as of Q2 2026.
- Two Sigma Securities bought 1,645 Idexx Laboratories shares in Q2 2026, an estimated $923K.
- Idexx Laboratories made up 0.12% of Two Sigma Securities's portfolio in Q2 2026, its #190 holding.
- Two Sigma Securities first reported a position in Idexx Laboratories in Q1 2017 and has held it in 23 quarters since.
- Two Sigma Securities's Idexx Laboratories position peaked at $1.68M in Q3 2017.
- 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.